Like other cancer types, c-MYC is highly expressed in endometrial tumors (Kim et al., 2013) and immunohistochemical localization studies revealed a 78.3% positive rate of c-MYC in endometrial cancer tissues with amplified c-MYC in 25% of the cases (Zhang et al., 2018; Buchynska et al., 2019). The gene discussed is MYC; the disease is endometrial cancer.